Breaking News Instant updates and real-time market news.

JNJ

Johnson & Johnson

$134.25

2.28 (1.73%)

09:05
02/13/19
02/13
09:05
02/13/19
09:05

Johnson & Johnson to acquire Auris Health for about $3.4B in cash

Johnson & Johnson announced that Ethicon entered into a definitive agreement to acquire Auris Health for approximately $3.4B in cash. Additional contingent payments of up to $2.35B, in the aggregate, may be payable upon reaching certain predetermined milestones. Auris Health is a privately held developer of robotic technologies, initially focused in lung cancer, with an FDA-cleared platform currently used in bronchoscopic diagnostic and therapeutic procedures. This acquisition will accelerate Johnson & Johnson's entry into robotics with potential for growth and expansion into other interventional applications. With this acquisition, Frederic Moll, M.D., CEO and Founder of Auris Health and a visionary in the field of surgical robotics, will be joining Johnson & Johnson upon completion of this transaction. The closing is subject to antitrust clearance and other customary closing conditions. The transaction is expected to close by the end of the second quarter of 2019. The company will discuss the transaction further during its next quarterly earnings call on April 16.

  • 18

    Feb

  • 25

    Feb

  • 06

    Mar

JNJ Johnson & Johnson
$134.25

2.28 (1.73%)

01/14/19
WELS
01/14/19
NO CHANGE
Target $152
WELS
Outperform
Johnson & Johnson price target lowered to $152 from $162 at Wells Fargo
Wells Fargo analyst Larry Biegelsen lowered his price target for Johnson & Johnson to $152 from $162 ahead of quarterly results. The analyst forecasts Q4 sales of $20.1B and EPS of $1.97, versus consensus of $20.2B and $1.95, respectively. For 2019, Biegelsen expects initial guidance to be conservative based on the company's track record, and J&J to continue to target earnings to grow faster than sales. The analyst sees 5%-6% operational EPS growth as "reasonable." He reiterates an Outperform rating on the shares.
01/24/19
BARD
01/24/19
NO CHANGE
Target $155
BARD
Outperform
HCA Healthcare elevated to Fresh Pick at Baird
Baird analyst Matthew Gillmor elevated HCA Healthcare (HCA) to Fresh Pick ahead of its Q4 report. The analyst said recent commentary from UnitedHealth (UNH) and Johnson & Johnson (JNJ) suggest Q4 patient volumes remain solid, which he thinks will translate into EBITDA upside for HCA. Gillmor reiterated his Outperform rating and $155 price target on HCA Healthcare shares.
01/28/19
PIPR
01/28/19
NO CHANGE
Target $38
PIPR
Overweight
MorphoSys weakness on patent ruling a buying opportunity, says Piper Jaffray
MorphoSys (MOR) shares are indicating down 5% this morning after the U.S. District Court sided against the company and ruled three of its patents invalid in a summary judgement of its lawsuit against Johnson & Johnson's (JNJ) Janssen this weekend, Piper Jaffray analyst Danielle Brill tells investors in a research note. The analyst is not surprised by the outcome and had low expectations for MorphoSys winning the case. The invalidated patents do not impact MorphoSys' drug MOR-202, and "very little has been lost" for the company, Brill writes. As such, she recommends buying the stock on today's weakness. The analyst keeps an Overweight rating on MorphoSys with a $38 price target.
02/05/19
PIPR
02/05/19
NO CHANGE
Target $161
PIPR
Overweight
Piper says argenx cusatuzumab study could enable registration if responses hold
Piper Jaffray analyst Edward Tenthoff reiterated an Overweight rating and $161 price target on argenx (ARGX) after the company announced a collaboration agreement with Halozyme (HALO). In a research note to investors, Tenthoff says that an ongoing Phase II study of cusatuzumab, which was licensed to Janssen (JNJ) after demonstrating a 92% response rate in AML at ASH, could enable registration if responses hold. The company will host an R&D Day in NYC on May 16 to introduce ARGX-117 and also expects the company will introduce ARGX-118.

TODAY'S FREE FLY STORIES

DBX

Dropbox

$25.58

0.1 (0.39%)

17:26
02/21/19
02/21
17:26
02/21/19
17:26
Earnings
Dropbox sees Q1 revenue $379M-$382M, consensus $377.03M »

Guidance taken from Q4…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 25

    Feb

EIDX

Eidos Therapeutics

$14.99

-0.64 (-4.09%)

17:25
02/21/19
02/21
17:25
02/21/19
17:25
Initiation
Eidos Therapeutics initiated  »

Eidos Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

  • 26

    Mar

NOC

Northrop Grumman

$287.50

-0.73 (-0.25%)

17:25
02/21/19
02/21
17:25
02/21/19
17:25
Hot Stocks
Northrop Grumman Australia unit to continue work on F-35 program »

Northrop Grumman…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

APPN

Appian

$38.73

0.41 (1.07%)

17:25
02/21/19
02/21
17:25
02/21/19
17:25
Earnings
Appian sees Q1 EPS (17c)-(16c), consensus (12c) »

Sees Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 25

    Feb

  • 25

    Feb

  • 26

    Feb

  • 07

    Mar

APPN

Appian

$38.73

0.41 (1.07%)

17:22
02/21/19
02/21
17:22
02/21/19
17:22
Earnings
Appian reports Q4 EPS (22c), consensus (16c) »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 25

    Feb

  • 25

    Feb

  • 26

    Feb

  • 07

    Mar

PTGX

Protagonist Therapeutics

$7.32

0.16 (2.23%)

17:20
02/21/19
02/21
17:20
02/21/19
17:20
Initiation
Protagonist Therapeutics initiated  »

Protagonist Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GT

Goodyear Tire

$19.19

-0.2 (-1.03%)

, WAB

Wabtec

$73.59

-1.425 (-1.90%)

17:20
02/21/19
02/21
17:20
02/21/19
17:20
Hot Stocks
Breaking Hot Stocks news story on Goodyear Tire, Wabtec »

Goodyear Tire to replace…

GT

Goodyear Tire

$19.19

-0.2 (-1.03%)

WAB

Wabtec

$73.59

-1.425 (-1.90%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Mar

WAB

Wabtec

$73.59

-1.425 (-1.90%)

, GT

Goodyear Tire

$19.19

-0.2 (-1.03%)

17:19
02/21/19
02/21
17:19
02/21/19
17:19
Hot Stocks
Wabtec to replace Goodyear Tire in S&P 500 at open on 2/27 »

General Electric (GE) is…

WAB

Wabtec

$73.59

-1.425 (-1.90%)

GT

Goodyear Tire

$19.19

-0.2 (-1.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Mar

BEAT

BioTelemetry

$73.39

-1.98 (-2.63%)

17:19
02/21/19
02/21
17:19
02/21/19
17:19
Earnings
BioTelemetry reports Q4 EPS 56c, consensus 43c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

NKTR

Nektar

$40.26

-2.76 (-6.42%)

17:18
02/21/19
02/21
17:18
02/21/19
17:18
Initiation
Nektar initiated  »

Nektar initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CONE

CyrusOne

$52.44

-4.75 (-8.31%)

17:16
02/21/19
02/21
17:16
02/21/19
17:16
Recommendations
CyrusOne analyst commentary  »

CyrusOne price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 11

    Mar

  • 11

    Mar

  • 18

    Jun

PLD

Prologis

$71.03

0.77 (1.10%)

17:16
02/21/19
02/21
17:16
02/21/19
17:16
Hot Stocks
Prologis raises quarterly dividend 10% to 53c per share »

Payable on March 29 to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MYOK

MyoKardia

$43.19

-0.43 (-0.99%)

17:14
02/21/19
02/21
17:14
02/21/19
17:14
Initiation
MyoKardia initiated  »

MyoKardia initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WPM

Wheaton Precious Metals

$21.75

-0.26 (-1.18%)

17:14
02/21/19
02/21
17:14
02/21/19
17:14
Hot Stocks
Wheaton Precious Metals produced 373,239 ounces of gold in 2018 »

Above forecast of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Mar

ENPH

Enphase Energy

$7.37

0.13 (1.80%)

17:13
02/21/19
02/21
17:13
02/21/19
17:13
Hot Stocks
Park West Asset Management reports 5.4% passive stake in Enphase Energy »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

WPM

Wheaton Precious Metals

$21.75

-0.26 (-1.18%)

17:12
02/21/19
02/21
17:12
02/21/19
17:12
Hot Stocks
Wheaton Precious Metals sees 365,000 ounces of gold produced in 2019 »

Wheaton's estimated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Mar

KHC

Kraft Heinz

$48.19

-0.05 (-0.10%)

17:10
02/21/19
02/21
17:10
02/21/19
17:10
Hot Stocks
Kraft Heinz says SEC probing procurement accounting policies »

The company said in a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

ACAM

Acamar Partners

$0.00

(0.00%)

17:10
02/21/19
02/21
17:10
02/21/19
17:10
Syndicate
Acamar Partners 30M share IPO priced at $10.00 »

Goldman Sachs and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMH

American Homes 4 Rent

$22.79

0.11 (0.49%)

17:07
02/21/19
02/21
17:07
02/21/19
17:07
Earnings
Breaking Earnings news story on American Homes 4 Rent »

American Homes 4 Rent…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

AMH

American Homes 4 Rent

$22.79

0.11 (0.49%)

17:06
02/21/19
02/21
17:06
02/21/19
17:06
Earnings
American Homes 4 Rent reports Q4 AFFO 25c, consensus 28c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

LPLA

LPL Financial

$76.68

-0.87 (-1.12%)

17:06
02/21/19
02/21
17:06
02/21/19
17:06
Hot Stocks
LPL Financial reports total brokerage, advisory assets at January-end up 5.2% »

Total brokerage and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

OMF

OneMain Holdings

$34.09

-0.45 (-1.30%)

17:05
02/21/19
02/21
17:05
02/21/19
17:05
Initiation
OneMain Holdings initiated  »

OneMain Holdings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 14

    Mar

KHC

Kraft Heinz

$48.19

-0.05 (-0.10%)

17:04
02/21/19
02/21
17:04
02/21/19
17:04
Hot Stocks
Breaking Hot Stocks news story on Kraft Heinz »

Kraft Heinz slips 8.8%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

EVRG

Evergy

$59.86

0.45 (0.76%)

17:02
02/21/19
02/21
17:02
02/21/19
17:02
Earnings
Breaking Earnings news story on Evergy »

Evergy reports Q4 pro…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

KHC

Kraft Heinz

$48.19

-0.05 (-0.10%)

17:02
02/21/19
02/21
17:02
02/21/19
17:02
Earnings
Kraft Heinz reports Q4 adjusted EPS 84c, consensus 94c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.